B
ISSUER//CIK 0001293971
bluebird bio, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K286.6 KBbluebird bio, Inc.Jun 2, 8:43 AM ET·0001193125-25-132850
- 10-Q6.6 MBbluebird bio, Inc.May 14, 5:14 PM ET·0001293971-25-000014
- 8-K209.6 KBbluebird bio, Inc.May 14, 8:53 AM ET·0001193125-25-119447
- 8-K162.3 KBbluebird bio, Inc.Mar 28, 4:37 PM ET·0001193125-25-067174
- 10-K11.1 MBbluebird bio, Inc.Mar 27, 4:58 PM ET·0001293971-25-000009
- 8-K1.2 MBbluebird bio, Inc.Feb 21, 8:21 AM ET·0001193125-25-031354
- 8-K148.2 KBbluebird bio, Inc.Feb 20, 4:35 PM ET·0001293971-25-000003
- 8-K179.5 KBbluebird bio, Inc.Dec 13, 4:04 PM ET·0001293971-24-000090
- 8-K156.2 KBbluebird bio, Inc.Dec 4, 4:05 PM ET·0001293971-24-000086
- SC 13G/A104.3 KBbluebird bio, Inc.Nov 14, 4:39 PM ET·0001172661-24-005271
Insiders
10- Agwunobi John ODirector
- ARCH Venture Fund VII, L.P.10% Owner
- Bain LindaVP, Fin. & Business Operations
- Baird William D IIIChief Financial Officer
- Birner Hubert10% Owner
- Burnett KatyPrincipal Accounting Officer
- BYBEE CLINTON10% Owner
- Cloonan MichaelDirector
- Cole JasonSVP, Secy. & General Counsel
- Colvin Richard AChief Medical Officer
Tickers
No tickers on record
Addresses
business
455 GRAND UNION BOULEVARD
SOMERVILLE, MA, 02145
mailing
455 GRAND UNION BOULEVARD
SOMERVILLE, MA, 02145
Former Names
- Genetix Pharmaceuticals Inc2010-03-19